Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical,HALIFAX Nova ScotiaBUSINESS WIREAppili Therapeutics Inc TSXV APLI the Company or Appili a publicly traded biopharmaceutical company focused on antiinfective drug development announced today it has signed an agreement with FUJIFILM Toyama Chemi 10174 chars,HALIFAX Nova ScotiaBUSINESS WIRE IMV AntibioticDeveloperAppili Therapeutics Acquires ATI2307 a clinical stage antifungal program From FUJIFILM Toyama Chemical
